Patents by Inventor David Loury

David Loury has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibitors of Bruton's tyrosine kinase
    Patent number: 9556182
    Abstract: Described herein are irreversible kinase inhibitor compounds, methods for synthesizing such irreversible inhibitors, and methods for using such irreversible inhibitors in the treatment of diseases. Further described herein are methods, assays and systems for determining an appropriate irreversible inhibitor of a protein, including a kinase.
    Type: Grant
    Filed: July 8, 2015
    Date of Patent: January 31, 2017
    Assignee: Pharmacylics LLC
    Inventors: Lee Honigberg, Erik Verner, Joseph J. Buggy, David Loury, Wei Chen
  • Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors
    Patent number: 9278100
    Abstract: Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
    Type: Grant
    Filed: December 30, 2011
    Date of Patent: March 8, 2016
    Assignee: Pharmacyclics LLC
    Inventors: Lee Honigberg, Erik Verner, Joseph Buggy, David Loury, Wei Chen
  • Inhibitors of bruton's tyrosine kinase
    Patent number: 9181263
    Abstract: Described herein are irreversible kinase inhibitor compounds, exemplified by compounds of the following structure: methods for synthesizing such irreversible inhibitors, and methods for using such irreversible inhibitors in the treatment of a disease such as cancer.
    Type: Grant
    Filed: January 26, 2015
    Date of Patent: November 10, 2015
    Assignee: PHARMACYCLICS LLC
    Inventors: Lee Honigberg, Erik Verner, Joseph J. Buggy, David Loury, Wei Chen
  • Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors
    Patent number: 8883803
    Abstract: Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
    Type: Grant
    Filed: December 30, 2011
    Date of Patent: November 11, 2014
    Assignee: Pharmacyclics, Inc.
    Inventors: Lee Honigberg, Erik Verner, Joseph Buggy, David Loury, Wei Chen
  • Inhibitors of Bruton's tyrosine kinase
    Patent number: 8883435
    Abstract: Described herein are irreversible kinase inhibitor compounds, methods for synthesizing such irreversible inhibitors, and methods for using such irreversible inhibitors in the treatment of diseases. Further described herein are methods, assays and systems for determining an appropriate irreversible inhibitor of a protein, including a kinase.
    Type: Grant
    Filed: March 27, 2008
    Date of Patent: November 11, 2014
    Assignee: Pharmacyclics, Inc.
    Inventors: Lee Honigberg, Erik Verner, Joseph J. Buggy, David Loury, Wei Chen
  • Inhibitors of Bruton's tyrosine kinase
    Patent number: 8809273
    Abstract: Described herein are irreversible kinase inhibitor compounds, methods for synthesizing such irreversible inhibitors, and methods for using such irreversible inhibitors in the treatment of diseases. Further described herein are methods, assays and systems for determining an appropriate irreversible inhibitor of a protein, including a kinase.
    Type: Grant
    Filed: December 29, 2011
    Date of Patent: August 19, 2014
    Assignee: Pharmacyclics, Inc.
    Inventors: Lee Honigberg, Erik Verner, Joseph J. Buggy, David Loury, Wei Chen
  • Manufacture, compositions and uses of coagulation factor VIIa modulator
    Patent number: 8748468
    Abstract: Treatment of cancer and thromboembolic disorders using inhibitors of Factor VIIa are disclosed herein using a compound of Formula I:
    Type: Grant
    Filed: November 2, 2012
    Date of Patent: June 10, 2014
    Assignee: Pharmacyclics, Inc.
    Inventors: David Loury, Tarak Mody
  • INHIBITORS OF BRUTON'S TYROSINE KINASE
    Publication number: 20140057907
    Abstract: Described herein are irreversible kinase inhibitor compounds, methods for synthesizing such irreversible inhibitors, and methods for using such irreversible inhibitors in the treatment of diseases. Further described herein are methods, assays and systems for determining an appropriate irreversible inhibitor of a protein, including a kinase.
    Type: Application
    Filed: October 31, 2013
    Publication date: February 27, 2014
    Applicant: PHARMACYCLICS, INC.
    Inventors: Lee HONIGBERG, Erik Verner, Joseph J. Buggy, David Loury, Wei Chen
  • Manufacture, compositions and uses of coagulation factor VIIa modulator
    Patent number: 8552046
    Abstract: Treatment of cancer and thromboembolic disorders using inhibitors of Factor VIIa are disclosed herein using a compound of Formula I.
    Type: Grant
    Filed: October 16, 2008
    Date of Patent: October 8, 2013
    Assignee: Pharmacyclics, Inc.
    Inventors: David Loury, Norbert Purro
  • INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS
    Publication number: 20130012525
    Abstract: Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
    Type: Application
    Filed: December 30, 2011
    Publication date: January 10, 2013
    Applicant: Pharmacylics, Inc.
    Inventors: Lee Honigberg, Erik Verner, Joseph Buggy, David Loury, Wei Chen
  • INHIBITORS OF BRUTONS TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS
    Publication number: 20130005746
    Abstract: Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
    Type: Application
    Filed: December 30, 2011
    Publication date: January 3, 2013
    Applicant: Pharmacyclics, Inc.
    Inventors: Lee Honigberg, Erik Verner, Joseph Buggy, David Loury, Wei Chen
  • INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS
    Publication number: 20110224235
    Abstract: Described herein are irreversible Btk inhibitor compounds, and methods for using such irreversible inhibitors in the treatment of diseases and disorders characterized by the presence or development of solid tumors.
    Type: Application
    Filed: July 16, 2009
    Publication date: September 15, 2011
    Applicant: PHARMACYCLICS, INC.
    Inventors: Lee Honigberg, Erik Verner, Joseph Buggy, David Loury, Wei Chen
  • MANUFACTURE, COMPOSITIONS AND USES OF COAGULATION FACTOR VIIa MODULATOR
    Publication number: 20100298396
    Abstract: Treatment of cancer and thromboembolic disorders using inhibitors of Factor VIIa are disclosed herein using a compound of Formula I.
    Type: Application
    Filed: October 16, 2008
    Publication date: November 25, 2010
    Applicant: PHARMACYCLICS, INC.
    Inventors: David Loury, Norbert Purro
  • METHOD AND APPARATUS FOR POWERING ON AN ELECTRONIC DEVICE WITH A VIDEO CAMERA THAT DETECTS MOTION
    Publication number: 20070136774
    Abstract: A method and apparatus for controlling power up of an electronic device with a video camera is provided. The present invention provides for using a video camera attached to an electronic device, such as a computer system, to cause the electronic device to be powered up from sleep mode when motion is detected. The electronic device may also be powered up from being shut down. In one embodiment, the video camera includes a processor and memory that compare consecutive frames captured by the video camera. When the electronic device is in sleep mode, if consecutive frames are the same, the video camera continues to monitor the scene without generating an output signal. If the frames are different, motion is detected and the video camera generates a signal that is used to determine whether the electronic device should power up. In this manner, the electronic device may begin the powering up process before the user of the device interacts with the device.
    Type: Application
    Filed: February 22, 2007
    Publication date: June 14, 2007
    Inventors: David Lourie, Pedro Fajardo, Gunner Danneels